MAGEC1 and plasma cell myeloma: Some exceptions to this observation among hematopoietic malignancies are the high expression of CT7/MAGE-C1 in multiple myeloma [13,14], and CT45 in classical Hodgkin lymphoma (cHL) [15,16].